Study design and rationale of the TXL-CAP trial: a randomized, double-blind, placebo-controlled, multicenter clinical trial assessing the effect of Tongxinluo capsules on the stability of coronary atherosclerotic plaques.
Recent clinical trials have demonstrated a protective effect in using traditional Chinese medicine Tongxinluo (TXL) capsule to treat atherosclerosis. However, clinical evidence of the effects of TXL treatment on coronary plaque vulnerability is unavailable. In response, we developed this study to in...
| Publicado en: | Journal of Geriatric Cardiology Vol. 22; no. 7; pp. 615 - 625 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | protocol tables/charts Journal Article |
| Publicado: |
Journal of Geriatric Cardiology
Jul2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |